Medicare Enrolled

Dr. Shahram Abrishamy, M.D.

Family Medicine · Marina Del Rey, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4560 ADMIRALTY WAY, Marina Del Rey, CA 90292
3103067100
In practice since 2007 (18 years)
NPI: 1649492448 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abrishamy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abrishamy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abrishamy

Dr. Shahram Abrishamy is a family medicine specialist in Marina Del Rey, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Abrishamy performed 581 Medicare services across 289 unique beneficiaries.

Between the years covered by Open Payments, Dr. Abrishamy received a total of $5,310 from 21 pharmaceutical and/or device companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abrishamy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 38% volume in CA $5,310 industry payments

Medicare Practice Summary

Medicare Utilization ↗
581
Medicare services
Top 38% in CA for family medicine
289
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~32 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
245 $6 $19
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
131 $63 $185
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
85 $47 $149
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
33 $78 $233
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
26 $97 $234
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
25 $95 $277
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
22 $84 $241
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $42 $124
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,310
Total received (2018-2024)
Avg $759/year across 7 years
Top 8% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
158
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,310 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$768
2023
$1,541
2022
$858
2021
$640
2020
$211
2019
$759
2018
$533

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$274
ABBVIE INC.
$193
Regeneron Healthcare Solutions, Inc.
$120
MERZ NORTH AMERICA, INC.
$102
REVANCE THERAPEUTICS, INC.
$56
Galderma Laboratories, L.P.
$22
Top 3 companies account for 76.5% of 2024 payments
All-time payments by company (2018-2024) ›
Merz North America, Inc.
$798
Galderma Laboratories, L.P.
$785
Regeneron Healthcare Solutions, Inc.
$661
Amgen Inc.
$632
Allergan Inc.
$376
AbbVie Inc.
$364
Allergan, Inc.
$355
MERZ NORTH AMERICA, INC.
$293
GENZYME CORPORATION
$223
ABBVIE INC.
$193
Celgene Corporation
$151
Sun Pharmaceutical Industries Inc.
$125
Novartis Pharmaceuticals Corporation
$115
REVANCE THERAPEUTICS, INC.
$56
SUN PHARMACEUTICAL INDUSTRIES INC.
$43
Lilly USA, LLC
$35
Janssen Biotech, Inc.
$31
AbbVie, Inc.
$23
Dermavant Sciences, Inc.
$23
VYNE Pharmaceuticals Inc.
$18
EPI Health, LLC
$9
Top 3 companies account for 42.3% of all-time payments
Associated products mentioned in payments ›
Absorica LD · BOTOX · BOTOX COSMETIC · COSENTYX · DAXXIFY · DUPIXENT · EPIDUO FORTE · Humira · Ilumya · KYBELLA · Otezla · Repatha · SKYRIZI · SOOLANTRA · Sitavig · TALTZ · TREMFYA · VTAMA · Winlevi · XEOMIN · Xeomin · ZILXI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for family medicine in CA.

Looking for a family medicine specialist in Marina Del Rey?
Compare family medicine physicians in the Marina Del Rey area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
2,970
Per 100K population
30.2
County median income
$87,760
Nearest hospital
CEDAR-SINAI MARINA DEL REY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Abrishamy is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 8% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Abrishamy experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Abrishamy performed 245 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abrishamy receive payments from pharmaceutical companies?
Yes. Dr. Abrishamy received a total of $5,310 from 21 companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abrishamy's costs compare to other family medicine physicians in Marina Del Rey?
Dr. Abrishamy's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abrishamy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →